Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0000950170-24-126622 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-13 | 2024-11-08 | WVE | Francis Chris | See Remarks | S - Sale+OE | $16.00 | -36.0K | 0 | -100% | -$576.0K |
| DT | 2024-11-13 | 2024-11-08 | WVE | Francis Chris | See Remarks | M - OptEx | $8.17 | +36.0K | 36.0K | New | +$294.1K |
| DT | 2024-11-13 | 2024-11-08 | WVE | Francis Chris | See Remarks | M - OptEx | $0.00 | -36.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-08 | S | D | 36,000 | $16.00 | 0 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-11-08 | M | A | 36,000 | $8.17 | 36,000 | D | — | — | |
| 3 | Derivative | Share Option (right to buy) | 2024-11-08 | M | D | 36,000 | $0.00 | 0 | D | $8.17 · — to 2030-03-03 | 36,000 Ordinary Shares | (F2) The share options that were exercised in this reportable transaction were fully vested. |